SBK2-ICG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SBK2-ICG, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG [Phase 1]